Shalby Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 13 Aug 2026

Company page: Shalby share price, financials & guidance record

Shalby Limited reported a mixed Q1 FY27, with strong consolidated revenue growth driven by robust performance in both hospital and MedTech segments. The hospital segment saw increased occupied beds and the Gurgaon unit achieved EBITDA break-even. However, consolidated and standalone hospital EBITDA margins compressed, and MedTech US remained marginally negative. Management expressed confidence in future margin improvement and ROCE expansion.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 11.8%, net profit up 25.0% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	268	276	265	296	285 +6%	272 −1%	287 +8%	331 +12%
Expenses	235	242	244	255	244	242	258	290
EBITDA	33	34	21	42	42 +27%	30 −12%	29 +38%	42 +0%
Margin	12%	12%	8%	14%	15%	11%	10%	13%
Other income	7	5	5	7	4	7	8	7
Interest	9	11	11	9	10	11	9	11
Depreciation	17	16	16	17	17	18	18	19
Profit before tax	14	12	-1	23	19 +36%	9 −25%	10 +1100%	20 −13%
Tax rate	83%	124%	1547%	66%	62%	86%	-92%	47%
Net profit	2	-3	-12	8	7 +250%	1 +133%	18 +250%	10 +25%
EPS	0.31	-0.17	-1.02	0.83	0.78	0.16	1.70	1.00

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Healthcare earnings calls